About Haeng-Gyu Lee

Haeng-Gyu Lee heads the Capital Markets Group of Jipyong LLC. As a leading lawyer in capital markets and private equity renowned for his strategic insight and meticulous approach, Haeng-Gyu has spearheaded some of the most notable capital markets transactions in recent years, including the listing of SK Biopharmaceuticals on the Korea Exchange, assisting issuers, sponsors and underwriters, financial institutions and private equity clients. Haeng-Gyu has consistently been honoured as the “Leading Lawyer” and “No 1 IPO Legal Advisory” by both domestic and international publications. Fluent in both Korean and English, Haeng-Gyu combines in-depth local knowledge with a global perspective to deliver innovative and tailored legal solutions that drive successful outcomes.

Contributions to Global Practice Guides

Equity Finance Trends and Developments in South Korea

Equity Finance Law and Practice in South Korea

}

Chambers and Partners make no representation or endorsement of the quality and services supplied by companies or firms that may be found on this website. In no event will Chambers and Partners be liable for any damages including, without limitation, indirect or consequential damages, or any damages whatsoever arising from use or loss of use, data, or profits, whether in action of contract, negligence or other tort action, arising out of or in connection with the use of the website.